HU0900677D0 - Extended release oral dosage composition - Google Patents

Extended release oral dosage composition

Info

Publication number
HU0900677D0
HU0900677D0 HU0900677A HUP0900677A HU0900677D0 HU 0900677 D0 HU0900677 D0 HU 0900677D0 HU 0900677 A HU0900677 A HU 0900677A HU P0900677 A HUP0900677 A HU P0900677A HU 0900677 D0 HU0900677 D0 HU 0900677D0
Authority
HU
Hungary
Prior art keywords
oral dosage
extended release
release oral
dosage composition
composition
Prior art date
Application number
HU0900677A
Other languages
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to HU0900677A priority Critical patent/HU0900677D0/en
Publication of HU0900677D0 publication Critical patent/HU0900677D0/en

Links

HU0900677A 2001-07-02 2001-07-02 Extended release oral dosage composition HU0900677D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HU0900677A HU0900677D0 (en) 2001-07-02 2001-07-02 Extended release oral dosage composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0900677A HU0900677D0 (en) 2001-07-02 2001-07-02 Extended release oral dosage composition

Publications (1)

Publication Number Publication Date
HU0900677D0 true HU0900677D0 (en) 2010-05-28

Family

ID=89989338

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0900677A HU0900677D0 (en) 2001-07-02 2001-07-02 Extended release oral dosage composition

Country Status (1)

Country Link
HU (1) HU0900677D0 (en)

Similar Documents

Publication Publication Date Title
HK1090840A1 (en) Extended release oral dosage composition
EG23759A (en) Stable extended release oral dosage composition
EG23943A (en) Flash-melt oral dosage formulation
PL367180A1 (en) Stabilized oral pharmaceutical composition
PL365518A1 (en) Oral composition
EP1407785A4 (en) Medicinal compositions
EP1553925A4 (en) Modified release oral dosage form
HK1065944A1 (en) Medicinal compositions
HUP0400850A3 (en) Oral pharmaceutical compositions
EP1411904A4 (en) Sustained release pharmaceutical composition
HK1065257A1 (en) Medicinal composition
HUP0500638A3 (en) Flashmelt oral dosage formulation
PL376840A1 (en) Prolonged release pharmaceutical composition
GB0126244D0 (en) Oral compositions
HUP0401599A3 (en) Extended release oral dosage form
EP1357898A4 (en) Improved controlled release oral dosage form
GB0114746D0 (en) Medicinal composition
HUP0301891A3 (en) Oral composition
HU0900677D0 (en) Extended release oral dosage composition
EP1413314A4 (en) Medicinal compositions
IL160372A0 (en) A new extended release oral dosage form
GB2376629B (en) Composition for oral hygiene
GB0118922D0 (en) Oral composition
AU2001293278A1 (en) Tableted oral extended release dosage form
PL373799A1 (en) Flashmelt oral dosage formulation

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: MERCK SHARP & DOHME CORP., US

Free format text: FORMER OWNER(S): SCHERING CORPORATION, US

FC4A Lapse of provisional application due to refusal